 | • レポートコード：GIR-107A15052 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、店頭販売（OTC）薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。店頭販売（OTC）薬の種類別市場規模（鎮痛剤、皮膚科製品、胃腸製品、ビタミン、ミネラル、サプリメント（VMS）、減量/ダイエット製品、眼科製品、睡眠補助剤、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・店頭販売（OTC）薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Bayer AG、Merck KGaA、Novartis、Johnson & Johnson、GlaxoSmithKline、Alkem Laboratories、Teva Pharmaceutical Industries、Pfizer、Sun Pharma、Allergan ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：鎮痛剤、皮膚科製品、胃腸製品、ビタミン、ミネラル、サプリメント（VMS）、減量/ダイエット製品、眼科製品、睡眠補助剤、その他 ・用途別分析2016年-2026年：病院薬局、小売薬局、オンライン薬局、その他 ・店頭販売（OTC）薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・店頭販売（OTC）薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・店頭販売（OTC）薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・店頭販売（OTC）薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・店頭販売（OTC）薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Over The Counter (OTC) Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Over The Counter (OTC) Drugs size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Over The Counter (OTC) Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Over The Counter (OTC) Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Analgesics
Dermatology Products
Gastrointestinal Products
Vitamins, Mineral, and Supplements (VMS)
Weight Loss/Dietary Products
Ophthalmic Products
Sleeping Aids
Others
Market segment by Application, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacy
Others
Market segment by players, this report covers
Bayer AG
Merck KGaA
Novartis
Johnson & Johnson
GlaxoSmithKline
Alkem Laboratories
Teva Pharmaceutical Industries
Pfizer
Sun Pharma
Allergan
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Over The Counter (OTC) Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Over The Counter (OTC) Drugs, with revenue, gross margin and global market share of Over The Counter (OTC) Drugs from 2019 to 2021.
Chapter 3, the Over The Counter (OTC) Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Over The Counter (OTC) Drugs market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Over The Counter (OTC) Drugs research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Over The Counter (OTC) Drugs
1.2 Classification of Over The Counter (OTC) Drugs by Type
1.2.1 Overview: Global Over The Counter (OTC) Drugs Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Over The Counter (OTC) Drugs Revenue Market Share by Type in 2020
1.2.3 Analgesics
1.2.4 Dermatology Products
1.2.5 Gastrointestinal Products
1.2.6 Vitamins, Mineral, and Supplements (VMS)
1.2.7 Weight Loss/Dietary Products
1.2.8 Ophthalmic Products
1.2.9 Sleeping Aids
1.2.10 Others
1.3 Global Over The Counter (OTC) Drugs Market by Application
1.3.1 Overview: Global Over The Counter (OTC) Drugs Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacy
1.3.5 Others
1.4 Global Over The Counter (OTC) Drugs Market Size & Forecast
1.5 Global Over The Counter (OTC) Drugs Market Size and Forecast by Region
1.5.1 Global Over The Counter (OTC) Drugs Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Over The Counter (OTC) Drugs Market Size by Region, (2016-2021)
1.5.3 North America Over The Counter (OTC) Drugs Market Size and Prospect (2016-2026)
1.5.4 Europe Over The Counter (OTC) Drugs Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Over The Counter (OTC) Drugs Market Size and Prospect (2016-2026)
1.5.6 South America Over The Counter (OTC) Drugs Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Over The Counter (OTC) Drugs Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Over The Counter (OTC) Drugs Market Drivers
1.6.2 Over The Counter (OTC) Drugs Market Restraints
1.6.3 Over The Counter (OTC) Drugs Trends Analysis
2 Company Profiles
2.1 Bayer AG
2.1.1 Bayer AG Details
2.1.2 Bayer AG Major Business
2.1.3 Bayer AG Over The Counter (OTC) Drugs Product and Solutions
2.1.4 Bayer AG Over The Counter (OTC) Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Bayer AG Recent Developments and Future Plans
2.2 Merck KGaA
2.2.1 Merck KGaA Details
2.2.2 Merck KGaA Major Business
2.2.3 Merck KGaA Over The Counter (OTC) Drugs Product and Solutions
2.2.4 Merck KGaA Over The Counter (OTC) Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Merck KGaA Recent Developments and Future Plans
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Over The Counter (OTC) Drugs Product and Solutions
2.3.4 Novartis Over The Counter (OTC) Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Novartis Recent Developments and Future Plans
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business
2.4.3 Johnson & Johnson Over The Counter (OTC) Drugs Product and Solutions
2.4.4 Johnson & Johnson Over The Counter (OTC) Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Johnson & Johnson Recent Developments and Future Plans
2.5 GlaxoSmithKline
2.5.1 GlaxoSmithKline Details
2.5.2 GlaxoSmithKline Major Business
2.5.3 GlaxoSmithKline Over The Counter (OTC) Drugs Product and Solutions
2.5.4 GlaxoSmithKline Over The Counter (OTC) Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 GlaxoSmithKline Recent Developments and Future Plans
2.6 Alkem Laboratories
2.6.1 Alkem Laboratories Details
2.6.2 Alkem Laboratories Major Business
2.6.3 Alkem Laboratories Over The Counter (OTC) Drugs Product and Solutions
2.6.4 Alkem Laboratories Over The Counter (OTC) Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Alkem Laboratories Recent Developments and Future Plans
2.7 Teva Pharmaceutical Industries
2.7.1 Teva Pharmaceutical Industries Details
2.7.2 Teva Pharmaceutical Industries Major Business
2.7.3 Teva Pharmaceutical Industries Over The Counter (OTC) Drugs Product and Solutions
2.7.4 Teva Pharmaceutical Industries Over The Counter (OTC) Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Teva Pharmaceutical Industries Recent Developments and Future Plans
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Over The Counter (OTC) Drugs Product and Solutions
2.8.4 Pfizer Over The Counter (OTC) Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Pfizer Recent Developments and Future Plans
2.9 Sun Pharma
2.9.1 Sun Pharma Details
2.9.2 Sun Pharma Major Business
2.9.3 Sun Pharma Over The Counter (OTC) Drugs Product and Solutions
2.9.4 Sun Pharma Over The Counter (OTC) Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Sun Pharma Recent Developments and Future Plans
2.10 Allergan
2.10.1 Allergan Details
2.10.2 Allergan Major Business
2.10.3 Allergan Over The Counter (OTC) Drugs Product and Solutions
2.10.4 Allergan Over The Counter (OTC) Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Allergan Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Over The Counter (OTC) Drugs Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Over The Counter (OTC) Drugs Players Market Share
3.2.2 Top 10 Over The Counter (OTC) Drugs Players Market Share
3.2.3 Market Competition Trend
3.3 Over The Counter (OTC) Drugs Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Over The Counter (OTC) Drugs Revenue and Market Share by Type (2016-2021)
4.2 Global Over The Counter (OTC) Drugs Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Over The Counter (OTC) Drugs Revenue Market Share by Application (2016-2021)
5.2 Over The Counter (OTC) Drugs Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Over The Counter (OTC) Drugs Revenue by Type (2016-2026)
6.2 North America Over The Counter (OTC) Drugs Revenue by Application (2016-2026)
6.3 North America Over The Counter (OTC) Drugs Market Size by Country
6.3.1 North America Over The Counter (OTC) Drugs Revenue by Country (2016-2026)
6.3.2 United States Over The Counter (OTC) Drugs Market Size and Forecast (2016-2026)
6.3.3 Canada Over The Counter (OTC) Drugs Market Size and Forecast (2016-2026)
6.3.4 Mexico Over The Counter (OTC) Drugs Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Over The Counter (OTC) Drugs Revenue by Type (2016-2026)
7.2 Europe Over The Counter (OTC) Drugs Revenue by Application (2016-2026)
7.3 Europe Over The Counter (OTC) Drugs Market Size by Country
7.3.1 Europe Over The Counter (OTC) Drugs Revenue by Country (2016-2026)
7.3.2 Germany Over The Counter (OTC) Drugs Market Size and Forecast (2016-2026)
7.3.3 France Over The Counter (OTC) Drugs Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Over The Counter (OTC) Drugs Market Size and Forecast (2016-2026)
7.3.5 Russia Over The Counter (OTC) Drugs Market Size and Forecast (2016-2026)
7.3.6 Italy Over The Counter (OTC) Drugs Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Over The Counter (OTC) Drugs Revenue by Type (2016-2026)
8.2 Asia-Pacific Over The Counter (OTC) Drugs Revenue by Application (2016-2026)
8.3 Asia-Pacific Over The Counter (OTC) Drugs Market Size by Region
8.3.1 Asia-Pacific Over The Counter (OTC) Drugs Revenue by Region (2016-2026)
8.3.2 China Over The Counter (OTC) Drugs Market Size and Forecast (2016-2026)
8.3.3 Japan Over The Counter (OTC) Drugs Market Size and Forecast (2016-2026)
8.3.4 South Korea Over The Counter (OTC) Drugs Market Size and Forecast (2016-2026)
8.3.5 India Over The Counter (OTC) Drugs Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Over The Counter (OTC) Drugs Market Size and Forecast (2016-2026)
8.3.7 Australia Over The Counter (OTC) Drugs Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Over The Counter (OTC) Drugs Revenue by Type (2016-2026)
9.2 South America Over The Counter (OTC) Drugs Revenue by Application (2016-2026)
9.3 South America Over The Counter (OTC) Drugs Market Size by Country
9.3.1 South America Over The Counter (OTC) Drugs Revenue by Country (2016-2026)
9.3.2 Brazil Over The Counter (OTC) Drugs Market Size and Forecast (2016-2026)
9.3.3 Argentina Over The Counter (OTC) Drugs Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Over The Counter (OTC) Drugs Revenue by Type (2016-2026)
10.2 Middle East & Africa Over The Counter (OTC) Drugs Revenue by Application (2016-2026)
10.3 Middle East & Africa Over The Counter (OTC) Drugs Market Size by Country
10.3.1 Middle East & Africa Over The Counter (OTC) Drugs Revenue by Country (2016-2026)
10.3.2 Turkey Over The Counter (OTC) Drugs Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Over The Counter (OTC) Drugs Market Size and Forecast (2016-2026)
10.3.4 UAE Over The Counter (OTC) Drugs Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Over The Counter (OTC) Drugs Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Over The Counter (OTC) Drugs Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Over The Counter (OTC) Drugs Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Over The Counter (OTC) Drugs Revenue (USD Million) by Region (2016-2021)
Table 5. Global Over The Counter (OTC) Drugs Revenue Market Share by Region (2021-2026)
Table 6. Bayer AG Corporate Information, Head Office, and Major Competitors
Table 7. Bayer AG Major Business
Table 8. Bayer AG Over The Counter (OTC) Drugs Product and Solutions
Table 9. Bayer AG Over The Counter (OTC) Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Merck KGaA Corporate Information, Head Office, and Major Competitors
Table 11. Merck KGaA Major Business
Table 12. Merck KGaA Over The Counter (OTC) Drugs Product and Solutions
Table 13. Merck KGaA Over The Counter (OTC) Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Novartis Corporate Information, Head Office, and Major Competitors
Table 15. Novartis Major Business
Table 16. Novartis Over The Counter (OTC) Drugs Product and Solutions
Table 17. Novartis Over The Counter (OTC) Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 19. Johnson & Johnson Major Business
Table 20. Johnson & Johnson Over The Counter (OTC) Drugs Product and Solutions
Table 21. Johnson & Johnson Over The Counter (OTC) Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 23. GlaxoSmithKline Major Business
Table 24. GlaxoSmithKline Over The Counter (OTC) Drugs Product and Solutions
Table 25. GlaxoSmithKline Over The Counter (OTC) Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Alkem Laboratories Corporate Information, Head Office, and Major Competitors
Table 27. Alkem Laboratories Major Business
Table 28. Alkem Laboratories Over The Counter (OTC) Drugs Product and Solutions
Table 29. Alkem Laboratories Over The Counter (OTC) Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Teva Pharmaceutical Industries Corporate Information, Head Office, and Major Competitors
Table 31. Teva Pharmaceutical Industries Major Business
Table 32. Teva Pharmaceutical Industries Over The Counter (OTC) Drugs Product and Solutions
Table 33. Teva Pharmaceutical Industries Over The Counter (OTC) Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Pfizer Corporate Information, Head Office, and Major Competitors
Table 35. Pfizer Major Business
Table 36. Pfizer Over The Counter (OTC) Drugs Product and Solutions
Table 37. Pfizer Over The Counter (OTC) Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Sun Pharma Corporate Information, Head Office, and Major Competitors
Table 39. Sun Pharma Major Business
Table 40. Sun Pharma Over The Counter (OTC) Drugs Product and Solutions
Table 41. Sun Pharma Over The Counter (OTC) Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Allergan Corporate Information, Head Office, and Major Competitors
Table 43. Allergan Major Business
Table 44. Allergan Over The Counter (OTC) Drugs Product and Solutions
Table 45. Allergan Over The Counter (OTC) Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Global Over The Counter (OTC) Drugs Revenue (USD Million) by Players (2019-2021)
Table 47. Global Over The Counter (OTC) Drugs Revenue Share by Players (2019-2021)
Table 48. Breakdown of Over The Counter (OTC) Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Over The Counter (OTC) Drugs Players Head Office, Products and Services Provided
Table 50. Over The Counter (OTC) Drugs Mergers & Acquisitions in the Past Five Years
Table 51. Over The Counter (OTC) Drugs New Entrants and Expansion Plans
Table 52. Global Over The Counter (OTC) Drugs Revenue (USD Million) by Type (2016-2021)
Table 53. Global Over The Counter (OTC) Drugs Revenue Share by Type (2016-2021)
Table 54. Global Over The Counter (OTC) Drugs Revenue Forecast by Type (2021-2026)
Table 55. Global Over The Counter (OTC) Drugs Revenue by Application (2016-2021)
Table 56. Global Over The Counter (OTC) Drugs Revenue Forecast by Application (2021-2026)
Table 57. North America Over The Counter (OTC) Drugs Revenue by Type (2016-2021) & (USD Million)
Table 58. North America Over The Counter (OTC) Drugs Revenue by Type (2021-2026) & (USD Million)
Table 59. North America Over The Counter (OTC) Drugs Revenue by Application (2016-2021) & (USD Million)
Table 60. North America Over The Counter (OTC) Drugs Revenue by Application (2021-2026) & (USD Million)
Table 61. North America Over The Counter (OTC) Drugs Revenue by Country (2016-2021) & (USD Million)
Table 62. North America Over The Counter (OTC) Drugs Revenue by Country (2021-2026) & (USD Million)
Table 63. Europe Over The Counter (OTC) Drugs Revenue by Type (2016-2021) & (USD Million)
Table 64. Europe Over The Counter (OTC) Drugs Revenue by Type (2021-2026) & (USD Million)
Table 65. Europe Over The Counter (OTC) Drugs Revenue by Application (2016-2021) & (USD Million)
Table 66. Europe Over The Counter (OTC) Drugs Revenue by Application (2021-2026) & (USD Million)
Table 67. Europe Over The Counter (OTC) Drugs Revenue by Country (2016-2021) & (USD Million)
Table 68. Europe Over The Counter (OTC) Drugs Revenue by Country (2021-2026) & (USD Million)
Table 69. Asia-Pacific Over The Counter (OTC) Drugs Revenue by Type (2016-2021) & (USD Million)
Table 70. Asia-Pacific Over The Counter (OTC) Drugs Revenue by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific Over The Counter (OTC) Drugs Revenue by Application (2016-2021) & (USD Million)
Table 72. Asia-Pacific Over The Counter (OTC) Drugs Revenue by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific Over The Counter (OTC) Drugs Revenue by Region (2016-2021) & (USD Million)
Table 74. Asia-Pacific Over The Counter (OTC) Drugs Revenue by Region (2021-2026) & (USD Million)
Table 75. South America Over The Counter (OTC) Drugs Revenue by Type (2016-2021) & (USD Million)
Table 76. South America Over The Counter (OTC) Drugs Revenue by Type (2021-2026) & (USD Million)
Table 77. South America Over The Counter (OTC) Drugs Revenue by Application (2016-2021) & (USD Million)
Table 78. South America Over The Counter (OTC) Drugs Revenue by Application (2021-2026) & (USD Million)
Table 79. South America Over The Counter (OTC) Drugs Revenue by Country (2016-2021) & (USD Million)
Table 80. South America Over The Counter (OTC) Drugs Revenue by Country (2021-2026) & (USD Million)
Table 81. Middle East & Africa Over The Counter (OTC) Drugs Revenue by Type (2016-2021) & (USD Million)
Table 82. Middle East & Africa Over The Counter (OTC) Drugs Revenue by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa Over The Counter (OTC) Drugs Revenue by Application (2016-2021) & (USD Million)
Table 84. Middle East & Africa Over The Counter (OTC) Drugs Revenue by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa Over The Counter (OTC) Drugs Revenue by Country (2016-2021) & (USD Million)
Table 86. Middle East & Africa Over The Counter (OTC) Drugs Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Over The Counter (OTC) Drugs Picture
Figure 2. Global Over The Counter (OTC) Drugs Revenue Market Share by Type in 2020
Figure 3. Analgesics
Figure 4. Dermatology Products
Figure 5. Gastrointestinal Products
Figure 6. Vitamins, Mineral, and Supplements (VMS)
Figure 7. Weight Loss/Dietary Products
Figure 8. Ophthalmic Products
Figure 9. Sleeping Aids
Figure 10. Others
Figure 11. Over The Counter (OTC) Drugs Revenue Market Share by Application in 2020
Figure 12. Hospital Pharmacies Picture
Figure 13. Retail Pharmacies Picture
Figure 14. Online Pharmacy Picture
Figure 15. Others Picture
Figure 16. Global Over The Counter (OTC) Drugs Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 17. Global Over The Counter (OTC) Drugs Revenue and Forecast (2016-2026) & (USD Million)
Figure 18. Global Over The Counter (OTC) Drugs Revenue Market Share by Region (2016-2026)
Figure 19. Global Over The Counter (OTC) Drugs Revenue Market Share by Region in 2020
Figure 20. North America Over The Counter (OTC) Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Europe Over The Counter (OTC) Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Asia-Pacific Over The Counter (OTC) Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 23. South America Over The Counter (OTC) Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 24. Middle East and Africa Over The Counter (OTC) Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 25. Over The Counter (OTC) Drugs Market Drivers
Figure 26. Over The Counter (OTC) Drugs Market Restraints
Figure 27. Over The Counter (OTC) Drugs Market Trends
Figure 28. Bayer AG Recent Developments and Future Plans
Figure 29. Merck KGaA Recent Developments and Future Plans
Figure 30. Novartis Recent Developments and Future Plans
Figure 31. Johnson & Johnson Recent Developments and Future Plans
Figure 32. GlaxoSmithKline Recent Developments and Future Plans
Figure 33. Alkem Laboratories Recent Developments and Future Plans
Figure 34. Teva Pharmaceutical Industries Recent Developments and Future Plans
Figure 35. Pfizer Recent Developments and Future Plans
Figure 36. Sun Pharma Recent Developments and Future Plans
Figure 37. Allergan Recent Developments and Future Plans
Figure 38. Global Over The Counter (OTC) Drugs Revenue Share by Players in 2020
Figure 39. Over The Counter (OTC) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 40. Global Top 3 Players Over The Counter (OTC) Drugs Revenue Market Share in 2020
Figure 41. Global Top 10 Players Over The Counter (OTC) Drugs Revenue Market Share in 2020
Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 43. Global Over The Counter (OTC) Drugs Revenue Share by Type in 2020
Figure 44. Global Over The Counter (OTC) Drugs Market Share Forecast by Type (2021-2026)
Figure 45. Global Over The Counter (OTC) Drugs Revenue Share by Application in 2020
Figure 46. Global Over The Counter (OTC) Drugs Market Share Forecast by Application (2021-2026)
Figure 47. North America Over The Counter (OTC) Drugs Sales Market Share by Type (2016-2026)
Figure 48. North America Over The Counter (OTC) Drugs Sales Market Share by Application (2016-2026)
Figure 49. North America Over The Counter (OTC) Drugs Revenue Market Share by Country (2016-2026)
Figure 50. United States Over The Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Canada Over The Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Mexico Over The Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Europe Over The Counter (OTC) Drugs Sales Market Share by Type (2016-2026)
Figure 54. Europe Over The Counter (OTC) Drugs Sales Market Share by Application (2016-2026)
Figure 55. Europe Over The Counter (OTC) Drugs Revenue Market Share by Country (2016-2026)
Figure 56. Germany Over The Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. France Over The Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. United Kingdom Over The Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Russia Over The Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Italy Over The Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Asia-Pacific Over The Counter (OTC) Drugs Sales Market Share by Type (2016-2026)
Figure 62. Asia-Pacific Over The Counter (OTC) Drugs Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Over The Counter (OTC) Drugs Revenue Market Share by Region (2016-2026)
Figure 64. China Over The Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Japan Over The Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South Korea Over The Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. India Over The Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Southeast Asia Over The Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Australia Over The Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. South America Over The Counter (OTC) Drugs Sales Market Share by Type (2016-2026)
Figure 71. South America Over The Counter (OTC) Drugs Sales Market Share by Application (2016-2026)
Figure 72. South America Over The Counter (OTC) Drugs Revenue Market Share by Country (2016-2026)
Figure 73. Brazil Over The Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Argentina Over The Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Middle East and Africa Over The Counter (OTC) Drugs Sales Market Share by Type (2016-2026)
Figure 76. Middle East and Africa Over The Counter (OTC) Drugs Sales Market Share by Application (2016-2026)
Figure 77. Middle East and Africa Over The Counter (OTC) Drugs Revenue Market Share by Country (2016-2026)
Figure 78. Turkey Over The Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Saudi Arabia Over The Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. UAE Over The Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Methodology
Figure 82. Research Process and Data Source
店頭販売（OTC）医薬品＆栄養補助食品市場：世界及び中国市場分析・予測（～2024年） Over the Counter (OTC) Drugs & Dietary Supplements Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Over the Counter (OTC) Drugs & Dietary Supplements industry with a focus on the Chinese market. The report provides key statist…- 世界のカウンターUAV市場 2021：企業別、地域別、種類・用途別 The Counter UAV market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent…
- 世界の店頭（OTC）鎮痛剤市場予測（～2024年） Over-the-counter pain relivers are a wide range of drugs which can be purchased without physician prescriptions and are used for acute pain-related conditions. Scope of the Report: The worldwide market for Over-The-Counter (OTC) Pain Relievers is expected to grow at a CAGR of roughly xx% over the ne…
- 世界のガンマカウンター市場 2021：企業別、地域別、種類・用途別 The Gamma Counter market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, rece…
- 世界の家畜用医薬品市場 2021：企業別、地域別、種類・用途別 The Farm Animal Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, …